QQubiotech Health Intelligence
Qubiotech Health Intelligence is a Galician health-AI company that develops Neurocloud, a cloud platform for automatic quantification of neuroimaging biomarkers from PET, SPECT and MRI scans to support diagnosis and monitoring of neurodegenerative conditions such as Alzheimer's, Parkinson's, epilepsy and multiple sclerosis. Founded in December 2014 as a spin-off from the Nuclear Medicine and Molecular Imaging group of the FIDIS health research institute in Santiago de Compostela, it is CE-marked and AEMPS-authorised and is used by roughly 20 hospitals in Spain and Portugal, including Hospital Clínic Barcelona and Hospital La Paz. It is a small seed-stage team (around 8-10 people) based in A Coruña.
SectorsHealthtech, Medical Imaging, Artificial Intelligence, Medical Devices / SaMD, Neurology
Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing
Founders
D
Daniel Fernández Mosquera
Co-founder & CEO
P
Pedro Arenas Barreiro
Co-founder
Global models 5
VViz.ai
United States · www.viz.ai ↗
Sells AI software to hospitals that automatically analyses brain scans (stroke, aneurysm) to support neurological diagnosis and care.
~$290MComparable
Iicometrix
Belgium · icometrix.com ↗
Sells CE-marked and FDA-cleared cloud software (icobrain) to hospitals and radiology departments that automatically measures brain MRI/CT biomarkers for MS, dementia and other neurodegenerative diseases, the closest match to Neurocloud.
~$55MComparable
BBrainomix
United Kingdom · www.brainomix.com ↗
Licenses AI imaging software (e-Stroke) to hospitals that reads neuro CT/MRI and reports quantitative results to support clinical decisions.
~$50MComparable
NNeurophet
South Korea · www.neurophet.com ↗
Sells AI software to hospitals that segments and measures brain MRI and PET scans for Alzheimer's diagnosis and monitoring, much like Neurocloud's biomarker quantification.
~$45MComparable
Q
Qynapse
France · qynapse.com ↗
Sells cloud software (QyScore) to hospitals and pharma trials that automatically measures brain MRI biomarkers for MS and Alzheimer's.
~$20MComparable
In the same niche 48 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 4
Open as list →
Funding rounds 2
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-05-08 | Seed | approximately €500K | Sémola Tech Ventures, Nowture |
| 2019-07-02 | Seed | €300K |
Lead not disclosed
+1 more
|